125 related articles for article (PubMed ID: 38043628)
21. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
Shen H; Yan W; Yuan J; Wang Z; Wang C
J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
[TBL] [Abstract][Full Text] [Related]
22. METTL3 orchestrates glycolysis by stabilizing the c-Myc/WDR5 complex in triple-negative breast cancer.
Yuan XN; Shao YC; Guan XQ; Liu Q; Chu MF; Yang ZL; Li H; Zhao S; Tian YH; Zhang JW; Wei L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119716. PubMed ID: 38547933
[TBL] [Abstract][Full Text] [Related]
23. β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.
Xu J; Prosperi JR; Choudhury N; Olopade OI; Goss KH
PLoS One; 2015; 10(2):e0117097. PubMed ID: 25658419
[TBL] [Abstract][Full Text] [Related]
24. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
25. METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/β-catenin pathway.
Ma X; Long C; Wang F; Lou B; Yuan M; Duan F; Yang Y; Li J; Qian X; Zeng J; Lin S; Shen H; Lin X
J Cell Mol Med; 2021 May; 25(9):4220-4234. PubMed ID: 33759344
[TBL] [Abstract][Full Text] [Related]
26. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
Morales F; Pérez P; Tapia JC; Lobos-González L; Herranz JM; Guevara F; de Santiago PR; Palacios E; Andaur R; Sagredo EA; Marcelain K; Armisén R
Gene; 2022 Apr; 819():146246. PubMed ID: 35122924
[TBL] [Abstract][Full Text] [Related]
27. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.
Ouyang D; Hong T; Fu M; Li Y; Zeng L; Chen Q; He H; Wen Y; Cheng Y; Zhou M; Zou Q; Yi W
Breast Cancer Res; 2023 Feb; 25(1):19. PubMed ID: 36765397
[TBL] [Abstract][Full Text] [Related]
28. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
29. Targeting Wnt/β-catenin signaling pathway in triple-negative breast cancer by benzylic organotrisulfides: Contribution of the released hydrogen sulfide towards potent anti-cancer activity.
Bhattacherjee D; Raina K; Mandal TK; Thummer RP; Bhabak KP
Free Radic Biol Med; 2022 Oct; 191():82-96. PubMed ID: 36038037
[TBL] [Abstract][Full Text] [Related]
30. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
31. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
32. METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer.
Jing L; Lan L; Mingxin Z; Zhaofeng Z
Sci Rep; 2022 Oct; 12(1):16715. PubMed ID: 36202872
[TBL] [Abstract][Full Text] [Related]
33. A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.
Xie W; Zhang Y; He Y; Zhang K; Wan G; Huang Y; Zhou Z; Huang G; Wang J
Int J Biochem Cell Biol; 2018 Oct; 103():45-55. PubMed ID: 30096373
[TBL] [Abstract][Full Text] [Related]
34. MiR-296-3p inhibits cell proliferation by the SOX4-Wnt/βcatenin pathway in triple-negative breast cancer.
Tian D; Luo L; Wang T; Qiao J
J Biosci; 2021; 46():. PubMed ID: 34785625
[TBL] [Abstract][Full Text] [Related]
35. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling.
Yu L; Wang C; Pan F; Liu Y; Ren X; Zeng H; Shi Y
Biomed Pharmacother; 2019 Oct; 118():109361. PubMed ID: 31545274
[TBL] [Abstract][Full Text] [Related]
36. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
[TBL] [Abstract][Full Text] [Related]
37. m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.
Huang C; Xu R; Zhu X; Jiang H
Cancer Gene Ther; 2023 Oct; 30(10):1426-1440. PubMed ID: 37563361
[TBL] [Abstract][Full Text] [Related]
38. Sesamol inhibits proliferation, migration and invasion of triple negative breast cancer via inactivating Wnt/β-catenin signaling.
Ma X; Hu X; Zhu Y; Jin H; Hu G; Ding L; Ning S
Biochem Pharmacol; 2022 Dec; 206():115299. PubMed ID: 36244446
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
[TBL] [Abstract][Full Text] [Related]
40. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J
Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
